United Kingdom · Question · Written question
UIN 181875
Medicines and Healthcare products Regulatory Agency: Finance
Original
Introduced
20 April 2023
Last action
27 April 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Healthcare
Source updated
27 April 2023
Summary
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of (a) staffing and (b) funding for the Medicines and Healthcare products Regulatory Agency in the context of the agency’s new respons
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 April 2023
Written question
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of (a) staffing and (b) funding for the Medicines and Healthcare products Regulatory Agency in the context of the agency’s new respons
Source: Commons
27 April 2023
Answer
As part of the Spring Budget, the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million of additional funding for the next two years. This is to support it to accelerate routes for bringing innovative medical products develop...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-04-20/181875
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1612781
- uk · wq-1612781 · source updated 27 April 2023